Skip to main content
Premium Trial:

Request an Annual Quote

Core Life Distributing Biogazelle qPCR Software in California

NEW YORK (GenomeWeb News) – Core Life Sciences announced this week that it and Biogazelle have reached an agreement to distribute Biogazelle's qbase+ software in California.

qbase+ is for the analysis of data from qPCR-based research. The product provides for normalization, quality control, and inter-run calibration in one software package. It can be used for experiments including mRNA gene expression profiling, mRNA gene expression analysis, miRNA profiling studies, miRNA validation studies, gene copy number analysis, and geNorm pilot studies for identifying stably expressed reference genes, Belgium-based Biogazelle said on its website.

Financial terms of the deal were not disclosed.

Core Life Sciences is based in Laguna Niguel, Calif., and distributes products and provides services to the life science research market.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.